Simpson Thacher represented Gordon Dyal & Co. in the transaction, while Davis Polk and Plesner advised Novozymes. Kromann Reumert has advised Novo Holdings and the Novo...
Novozymes’ $12.3 Billion Merger with Chr. Hansen
Novozymes’ $12.3 Billion Merger with Chr. Hansen
Simpson Thacher represented Gordon Dyal & Co. in the transaction. Novozymes A/S announced its definitive agreement to acquire Chr. Hansen Holding A/S (“Chr. Hansen”) in a statutory...